Recent Updates
Recently added Catalysts
CHRS Positive Sentiment Score: 70/100

Coherus BioSciences Announces New Employment Inducement Grants

Friday, July 21, 2023 1 min read
Key Takeaway: Coherus BioSciences has announced the granting of employment inducement stock options totaling 187,000 shares to newly hired employees, effective July 20, 2023. The options include a significant allocation for a Senior Vice President and additional grants for five non-officer employees. This move is aimed at attracting talent as part of the company's ongoing strategy to enhance its workforce under its approved Employment Commencement Incentive Plan.

Market Sentiment Analysis

POSITIVE FACTORS

  • The grant of stock options can attract talented individuals to the company.
  • The employment inducement grants reflect confidence in future growth and potential.
  • Percentage of stock options for senior positions suggests strategic hiring.

Full Press Release Details

REDWOOD CITY, Calif., July 21, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective July 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 187,000 shares of the common stock of the Company to newly hired employees with a per share exercise price of $4.17, the closing trading price on the grant date. One Senior Vice President level executive was granted options to purchase 100,000 shares; and five additional non-officer employees were granted options to purchase an aggregate of 87,000 shares.
The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Coherus BioSciences Contact Information:
Coherus BioSciences, Inc.

Frequently Asked Questions

What recent stock option grant did Coherus announce?

Coherus granted options to purchase 187,000 shares to new employees.

What was the exercise price for the stock options?

The exercise price was set at $4.17, the closing price on the grant date.

How many shares were granted to the Senior Vice President?

The Senior Vice President received options to purchase 100,000 shares.

Which plan was used for the stock option grants?

The grants were made under the 2016 Employment Commencement Incentive Plan.

When was the stock option grant effective?

The grant became effective on July 20, 2023.

Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences employment grants stock options biopharmaceuticals
Last updated: Jul 21, 2023